Source: Interfolio F180
Christopher Parker
Education
Ph.D. (Chemistry), Yale University, 2013B.S. (Chemistry), Case Western Reserve University, 2007
Professional Experience
American Cancer Society Postdoctoral Fellow, The Scripps Research Institute, 2013-2018Awards & Professional Activities
2018 BMS, Bristol Myers Squibb2020 W81XWH2010431, DOD
2021 Belharra, Belharra Therapeutics
2021 R61-NS119658, Moffit Cancer Center
2022 AbbVie
2022 R01-AI156268-01, National Institutes of Health
2022 U19AI71443-01, NIH
2022 Parker/SFP-0204, Inception Therapeutics/Parker Co
2023, CZI
Selected Publications
Parker, Christopher G.; Forrest, Ines
Proteome-Wide Fragment-Based Ligand and Target Discovery
. Israel Journal of Chemistry 2023.[View]
Parker, Christopher; Lairson, Luke; Tang, Junchen; Li, Weichao; Chiu, Tzu-Yuan; Luo, Zengwei; Chong, Christine; Wei, Qijia; Martínez-Peña, Francisco; Gazaniga, Nathalia; See, Yi Yang; Baran, Phil
A Scalable Total Synthesis of Portimine A and B Reveals the Basis of Their Potent and Selective Anti-cancer Activity
. 2023.[View]
parker, christopher g.; teijaro, john; gazaniga, nathalia; wozniak, jacob m.; jadhav, appaso m.; li, weichao; chiu, tzu-yuan; wang, wesley w.; lazar, daniel c.
Chemoproteomics-guided development of SLC15A4 inhibitors with anti-inflammatory activity
. Cold Spring Harbor Laboratory - bioRxiv 2022.[View]
Parker, Christopher G.; Wang, Wesley W.; Chen, Li-Yun; Wozniak, Jacob M.; Jadhav, Appaso M.; Anderson, Hayden; Malone, Taylor E. Targeted Protein Acetylation in Cells Using Heterobifunctional Molecules. Journal of the American Chemical Society 2021, 143, 16700-16708.
[View]
Rubiano, Juanita S.; Parker, Christopher G.; Li, Weichao; Lawrence, R M.; Jadhav, Appaso M.; Homan, Rick A.; Hawkins, Richard; Conway, Louis P. Evaluation of fully-functionalized diazirine tags for chemical proteomic applications.. Chemical science 2021, 7839-7847.
Parker, Christopher G.; Yoo, Daniel Y.; Richards-corke, Khyle C.; Parker, Christopher G.; Hong, Seong H.; Conway, Louis P.; Arora, Paramjit S. A Sos proteomimetic as a pan-Ras inhibitor.. Proceedings of the National Academy of Sciences of the United States of America 2021.